Neurocrine Biosciences
NBIX
NBIX
244 hedge funds and large institutions have $4.32B invested in Neurocrine Biosciences in 2016 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 85 increasing their positions, 88 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
3% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 88
Holders
244
Holding in Top 10
7
Calls
$39.2M
Puts
$8.02M
Top Buyers
| 1 | +$50.3M | |
| 2 | +$50.2M | |
| 3 | +$32.7M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$23.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.4M |
Top Sellers
| 1 | -$25.7M | |
| 2 | -$22.3M | |
| 3 | -$20.5M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$16.3M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$13.8M |